This episode breaks down why ISO 13485 certification alone does not make a MedTech company FDA-ready under QMSR, and why the real differentiator is operational readiness under real-world pressure. Rita King and Evangelia Evdaimon explain how to connect quality, regulatory, risk, complaints, and post‑market activities into a truly inspection‑ready system, and why AI-enabled eQMS platforms like LuminLogic can help teams align with QMSR and ISO 13485 while improving visibility, traceability, and defensible decision‑making across the product lifecycle. Available for download is our FREE QMSR Operational Readiness & ISO 13485 Traceability Checklist. This scoring-based tool lets you benchmark each subsystem, expose hidden inspection risk, and see exactly how close your QMS is to being fully integrated, scalable, and inspection‑ready. https://methodsense.com/ep-7-qmsr-and-iso-13485-understanding-the-difference-between-compliance-and-readiness/

This episode breaks down why ISO 13485 certification alone does not make a MedTech company FDA-ready under QMSR, and why the real differentiator is operational readiness under real-world pressure. Rita King and Evangelia Evdaimon explain how to connect quality, regulatory, risk, complaints, and post‑market activities into a truly inspection‑ready system, and why AI-enabled eQMS platforms like LuminLogic can help teams align with QMSR and ISO 13485 while improving visibility, traceability, and defensible decision‑making across the product lifecycle.Available for download is our FREE QMSR Operational Readiness & ISO 13485 Traceability Checklist. This scoring-based tool lets you benchmark each subsystem, expose hidden inspection risk, and see exactly how close your QMS is to being fully integrated, scalable, and inspection‑ready. https://methodsense.com/ep-7-qmsr-and-iso-13485-understanding-the-difference-between-compliance-and-readiness/ 

MedTech Smarts with Rita

Ep. 7 - QMSR and ISO 13485: Understanding the Difference Between Compliance and Readiness

In this episode of MedTech Smarts with Rita, we break down the FDA’s new Quality Management System Regulation (QMSR), what it means for medical device companies and how to successfully transition to this more proactive, integrated approach to quality management. Our QMSR Readiness Snapshot helps you assess how your organization truly operates: decision‑making speed, information flow across teams, and consistency of data‑driven action. Download the snapshot document to get a clear picture of your current state in minutes. https://methodsense.com/ep-6-what-qmsr-means-and-why-it-matters-now/

In this episode of MedTech Smarts with Rita, we break down the FDA’s new Quality Management System Regulation (QMSR), what it means for medical device companies and how to successfully transition to this more proactive, integrated approach to quality management.Our QMSR Readiness Snapshot helps you assess how your organization truly operates: decision‑making speed, information flow across teams, and consistency of data‑driven action. Download the snapshot document to get a clear picture of your current state in minutes. https://methodsense.com/ep-6-what-qmsr-means-and-why-it-matters-now/

Ep. 6 - What QMSR Means and Why it Matters Now

In this episode of MedTech Smarts with Rita, regulatory strategist Rita King breaks down what it means to operate as a true medical device company, beyond just building a product. She explains how understanding FDA definitions, designing with compliance in mind, and aligning your marketing language can help founders move faster, gain investor confidence, and build lasting credibility in the MedTech space.

In this episode of MedTech Smarts with Rita, regulatory strategist Rita King breaks down what it means to operate as a true medical device company, beyond just building a product. She explains how understanding FDA definitions, designing with compliance in mind, and aligning your marketing language can help founders move faster, gain investor confidence, and build lasting credibility in the MedTech space.

Ep. 5 - What It Really Means to Be a Medical Device Company

On this episode of MedTech Smarts with Rita, Anna Crooke, Rita King, and Shavini Fernando dive into the realities of bringing a medical device to market. Drawing on Shavini’s journey with OxiWear, a pioneering pulse oximeter, the conversation explores the hurdles of FDA submissions, the pressure of investor expectations, and why early collaboration is critical. The discussion highlights how transparency, strategic planning, and strong partnerships between founders, investors, and regulatory experts are essential to turning innovation into lasting success in the medical device industry.

On this episode of MedTech Smarts with Rita, Anna Crooke, Rita King, and Shavini Fernando dive into the realities of bringing a medical device to market. Drawing on Shavini’s journey with OxiWear, a pioneering pulse oximeter, the conversation explores the hurdles of FDA submissions, the pressure of investor expectations, and why early collaboration is critical. The discussion highlights how transparency, strategic planning, and strong partnerships between founders, investors, and regulatory experts are essential to turning innovation into lasting success in the medical device industry.

Ep. 4 - Regulatory Efficiency Under Pressure: A Founder-Expert Perspective

This week on MedTech Smarts with Rita, the panel tackles today’s toughest funding challenges in MedTech, from shrinking venture capital to limited grants and the impact on commercialization timelines. Special guest Nikin Shah reveals how creative lending and strategic partnerships offer fresh pathways for growth, while experts Rita and Richard share actionable insights for leveraging regulatory planning as a business asset. The episode spotlights tools like LuminLogic, showing how robust compliance systems can boost investor confidence and accelerate execution. Whether you're a founder or investor, this discussion delivers strategies for navigating the capital crunch and building scalable, resilient MedTech companies.

This week on MedTech Smarts with Rita, the panel tackles today’s toughest funding challenges in MedTech, from shrinking venture capital to limited grants and the impact on commercialization timelines. Special guest Nikin Shah reveals how creative lending and strategic partnerships offer fresh pathways for growth, while experts Rita and Richard share actionable insights for leveraging regulatory planning as a business asset. The episode spotlights tools like LuminLogic, showing how robust compliance systems can boost investor confidence and accelerate execution. Whether you're a founder or investor, this discussion delivers strategies for navigating the capital crunch and building scalable, resilient MedTech companies.

Ep. 3 - Funding Innovation: Smart Capital Strategies in a Tight MedTech Market

This week on MedTech Smarts with Rita, we're launching a special mini-series called "Before You Build It: Lessons from 25 Years of MedTech Startups." We'll dive into the realities of building a medical device startup from securing funding to navigating FDA clearance. Join industry veterans Rita King and Richard Holcomb as they unpack what most founders wish they'd known early on so they could get it right from the very beginning.

This week on MedTech Smarts with Rita, we're launching a special mini-series called "Before You Build It: Lessons from 25 Years of MedTech Startups." We'll dive into the realities of building a medical device startup from securing funding to navigating FDA clearance. Join industry veterans Rita King and Richard Holcomb as they unpack what most founders wish they'd known early on so they could get it right from the very beginning.

Ep 2. - Before You Build It: Lessons from 25 Years of MedTech Startups

On this episode of MedTech Smarts with Rita, MethodSense founder and CEO Rita King joins Anna Crooke to take a closer look at one of the most talked about advancements at the FDA: their new artificial intelligence tool, Elsa. Anna and Rita break down what Elsa means for MedTech executives, why it’s making waves in the industry, and how this tool could shape the future of medical device regulation.

On this episode of MedTech Smarts with Rita, MethodSense founder and CEO Rita King joins Anna Crooke to take a closer look at one of the most talked about advancements at the FDA: their new artificial intelligence tool, Elsa. Anna and Rita break down what Elsa means for MedTech executives, why it’s making waves in the industry, and how this tool could shape the future of medical device regulation. 

Ep 1. - Essentials for Navigating FDA’s AI Elsa

Welcome to MedTech Smarts with Rita, the podcast by MethodSense where we bring you essential insights for MedTech executives. Each episode delivers actionable strategies, expert interviews, and guidance for regulatory and compliance issues that help you and your investors bring innovative medical devices and technology to the market faster. Whether you’re a seasoned leader or an emerging startup, join Rita King as she explores topics ranging from regulatory compliance and innovation to leadership challenges and patient-centered solutions. Stay ahead of the curve, gain fresh perspectives, and make smarter decisions for your MedTech organization

Welcome to MedTech Smarts with Rita, the podcast by MethodSense where we bring you essential insights for MedTech executives. Each episode delivers actionable strategies, expert interviews, and guidance for regulatory and compliance issues that help you and your investors bring innovative medical devices and technology to the market faster. Whether you’re a seasoned leader or an emerging startup, join Rita King as she explores topics ranging from regulatory compliance and innovation to leadership challenges and patient-centered solutions. Stay ahead of the curve, gain fresh perspectives, and make smarter decisions for your MedTech organization

hubhopper

MedTech Smarts with Rita

hubhopper